一种新型的电子健康记录集成肾结石临床途径:发展和管理结果。

IF 1.7 Q4 UROLOGY & NEPHROLOGY
Urology Practice Pub Date : 2025-09-01 Epub Date: 2025-06-03 DOI:10.1097/UPJ.0000000000000847
Soum D Lokeshwar, Ankur U Choksi, Shayan Smani, Daniel Heacock, Naga S Kanaparthy, Devin M Shaheen, Meir Dashevsky, Thomas Martin, Dinesh Singh, Piruz Motamedinia, Rohit B Sangal
{"title":"一种新型的电子健康记录集成肾结石临床途径:发展和管理结果。","authors":"Soum D Lokeshwar, Ankur U Choksi, Shayan Smani, Daniel Heacock, Naga S Kanaparthy, Devin M Shaheen, Meir Dashevsky, Thomas Martin, Dinesh Singh, Piruz Motamedinia, Rohit B Sangal","doi":"10.1097/UPJ.0000000000000847","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Acute renal colic from nephrolithiasis is a common condition in emergency departments (EDs). Variation in clinical management contributes to unnecessary opioid use, inadequate discharge planning, and repeat visits. To address these challenges, we implemented an electronic health record-integrated clinical pathway to standardize management. We aimed to enhance pain control, streamline discharge practices, and optimize overall ED patient care. This study evaluates the impact of this pathway on important nephrolithiasis management process measures.</p><p><strong>Methods: </strong>This retrospective cohort study examined patients presenting with renal colic or ureteral stones at 9 EDs in a northeast health system between January 1 and December 31, 2023. Outcomes analyzed included utilization of opioid alternatives (eg, lower-dose ketorolac and IV lidocaine), 28-day tamsulosin prescription at discharge, and time to urology follow-up. Statistical methods included Mann-Whitney <i>U</i> tests, Pearson χ<sup>2</sup> tests, and logistic regression.</p><p><strong>Results: </strong>Of 5733 patients, 585 (10.2%) were managed through the nephrolithiasis pathway, while 5148 received standard care. Pathway use increased administration of the recommended ketorolac dose (33.2% vs 26.8%, <i>P</i> = .006), intravenous lidocaine use (5.6% vs 0.8%, <i>P</i> < .001), and 28-day tamsulosin prescriptions (22.7% vs 6.8%, <i>P</i> < .001). Multivariate analysis identified pathway utilization as a significant predictor for each intervention (ketorolac 15 mg dose: OR: 1.37, 95% CI: 1.10-1.71, <i>P</i> = .004; IV lidocaine: OR: 6.54, 95% CI: 4.09-10.46, <i>P</i> < .001; tamsulosin: OR: 3.78, 95% CI: 2.97-4.79, <i>P</i> < .001).</p><p><strong>Conclusions: </strong>The electronic health record-integrated nephrolithiasis pathway effectively promoted evidence-based pain management promoting nonopioid pain control and appropriate medical expulsive therapy.</p>","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"603-612"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Novel Electronic Health Record-Integrated Clinical Pathway for Nephrolithiasis: Development and Management Outcomes.\",\"authors\":\"Soum D Lokeshwar, Ankur U Choksi, Shayan Smani, Daniel Heacock, Naga S Kanaparthy, Devin M Shaheen, Meir Dashevsky, Thomas Martin, Dinesh Singh, Piruz Motamedinia, Rohit B Sangal\",\"doi\":\"10.1097/UPJ.0000000000000847\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Acute renal colic from nephrolithiasis is a common condition in emergency departments (EDs). Variation in clinical management contributes to unnecessary opioid use, inadequate discharge planning, and repeat visits. To address these challenges, we implemented an electronic health record-integrated clinical pathway to standardize management. We aimed to enhance pain control, streamline discharge practices, and optimize overall ED patient care. This study evaluates the impact of this pathway on important nephrolithiasis management process measures.</p><p><strong>Methods: </strong>This retrospective cohort study examined patients presenting with renal colic or ureteral stones at 9 EDs in a northeast health system between January 1 and December 31, 2023. Outcomes analyzed included utilization of opioid alternatives (eg, lower-dose ketorolac and IV lidocaine), 28-day tamsulosin prescription at discharge, and time to urology follow-up. Statistical methods included Mann-Whitney <i>U</i> tests, Pearson χ<sup>2</sup> tests, and logistic regression.</p><p><strong>Results: </strong>Of 5733 patients, 585 (10.2%) were managed through the nephrolithiasis pathway, while 5148 received standard care. Pathway use increased administration of the recommended ketorolac dose (33.2% vs 26.8%, <i>P</i> = .006), intravenous lidocaine use (5.6% vs 0.8%, <i>P</i> < .001), and 28-day tamsulosin prescriptions (22.7% vs 6.8%, <i>P</i> < .001). Multivariate analysis identified pathway utilization as a significant predictor for each intervention (ketorolac 15 mg dose: OR: 1.37, 95% CI: 1.10-1.71, <i>P</i> = .004; IV lidocaine: OR: 6.54, 95% CI: 4.09-10.46, <i>P</i> < .001; tamsulosin: OR: 3.78, 95% CI: 2.97-4.79, <i>P</i> < .001).</p><p><strong>Conclusions: </strong>The electronic health record-integrated nephrolithiasis pathway effectively promoted evidence-based pain management promoting nonopioid pain control and appropriate medical expulsive therapy.</p>\",\"PeriodicalId\":45220,\"journal\":{\"name\":\"Urology Practice\",\"volume\":\" \",\"pages\":\"603-612\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urology Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/UPJ.0000000000000847\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/UPJ.0000000000000847","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/3 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:肾结石引起的急性肾绞痛是急诊科的常见病。临床管理的差异导致不必要的阿片类药物使用,不充分的出院计划和重复就诊。为了应对这些挑战,我们实施了电子健康记录集成临床路径,以标准化管理。我们的目标是加强疼痛控制,简化出院实践,并优化整体急诊科患者护理。本研究评估了该途径对重要肾结石管理过程措施的影响。材料和方法:本回顾性队列研究调查了2023年1月1日至12月31日期间东北卫生系统9个急诊科出现肾绞痛或输尿管结石的患者。结果分析包括阿片类药物替代品的使用(如低剂量酮咯酸和静脉注射利多卡因),出院时28天坦索罗辛处方,以及泌尿外科随访时间。统计方法包括Mann-Whitney U检验、Pearson卡方检验和logistic回归。结果:在5733例患者中,585例(10.2%)通过肾结石途径进行了治疗,而5148例接受了标准治疗。途径的使用增加了酮洛酸推荐剂量的使用(33.2%对26.8%,p=0.006),静脉注射利多卡因的使用(5.6%对0.8%)。结论:电子健康记录集成肾结石途径有效地促进了循证疼痛管理,促进了非阿片类药物疼痛的控制,以及适当的医疗排出治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Novel Electronic Health Record-Integrated Clinical Pathway for Nephrolithiasis: Development and Management Outcomes.

Introduction: Acute renal colic from nephrolithiasis is a common condition in emergency departments (EDs). Variation in clinical management contributes to unnecessary opioid use, inadequate discharge planning, and repeat visits. To address these challenges, we implemented an electronic health record-integrated clinical pathway to standardize management. We aimed to enhance pain control, streamline discharge practices, and optimize overall ED patient care. This study evaluates the impact of this pathway on important nephrolithiasis management process measures.

Methods: This retrospective cohort study examined patients presenting with renal colic or ureteral stones at 9 EDs in a northeast health system between January 1 and December 31, 2023. Outcomes analyzed included utilization of opioid alternatives (eg, lower-dose ketorolac and IV lidocaine), 28-day tamsulosin prescription at discharge, and time to urology follow-up. Statistical methods included Mann-Whitney U tests, Pearson χ2 tests, and logistic regression.

Results: Of 5733 patients, 585 (10.2%) were managed through the nephrolithiasis pathway, while 5148 received standard care. Pathway use increased administration of the recommended ketorolac dose (33.2% vs 26.8%, P = .006), intravenous lidocaine use (5.6% vs 0.8%, P < .001), and 28-day tamsulosin prescriptions (22.7% vs 6.8%, P < .001). Multivariate analysis identified pathway utilization as a significant predictor for each intervention (ketorolac 15 mg dose: OR: 1.37, 95% CI: 1.10-1.71, P = .004; IV lidocaine: OR: 6.54, 95% CI: 4.09-10.46, P < .001; tamsulosin: OR: 3.78, 95% CI: 2.97-4.79, P < .001).

Conclusions: The electronic health record-integrated nephrolithiasis pathway effectively promoted evidence-based pain management promoting nonopioid pain control and appropriate medical expulsive therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Urology Practice
Urology Practice UROLOGY & NEPHROLOGY-
CiteScore
1.80
自引率
12.50%
发文量
163
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信